Singapore Antibody Drug Conjugates (ADC) Market to 2032

Overview

The Singapore Antibody Drug Conjugates (ADC) Market is expected to reach a 488.11 USD Million by 2032 and is projected to grow at a CAGR of 18.80% from 2025 to 2032.

Revenue, 2024 (USD Million)

146.17

Forecast, 2032 (USD Million)

488.11

CAGR, 2024 - 2032

18.80%

Report Coverage

Singapore

Singapore Antibody Drug Conjugates (ADC) Market 2018-2032 USD Million

Singapore Antibody Drug Conjugates (ADC) Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 146.17 USD Million
Projected Market Size (2032): 488.11 USD Million
CAGR (2025-2032): 18.80%

Key Findings of Singapore Antibody Drug Conjugates (ADC) Market

The Singapore Antibody Drug Conjugates (ADC) Market was valued at 146.17 USD Million in 2024.
The Singapore Antibody Drug Conjugates (ADC) Market is likely to grow at a CAGR of 18.80% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Cleavable Linkers in Linkers Component Segment accounted for the largest share of the market with a revenue of 117.28 USD Million
The fastest growing segment Ambulatory Centers in End User Segment grew Fastest with a CAGR of 20.07% during the forecast period from 2024 to 2032.

Singapore Antibody Drug Conjugates (ADC) Market Scope

Singapore Antibody Drug Conjugates (ADC) Market Segmentation & Scope

Indication

Others
Genitourinary Cancer
Gastrointestinal Cancer
Gynecological Cancer
Lung Cancer
Blood Cancer (Leukemia, Lymphoma)
Breast Cancer

Conjugation Technology

Chemical Conjugation
Site-Specific Conjugation

Linker Technology

Disulfide Linkers
Hydrazone Linkers
Thioether Linkers
Peptide Linkers

Cytotoxic Payloads or Warheads Component

Microtubule Disrupting Agents
DNA Damaging Agents

End User

Home Healthcare
Others
Ambulatory Centers
Clinics
Specialty Center
Hospitals

Distribution Channel

Others
Retail Sales
Direct Tenders

Linkers Component

Non Cleavable Linkers
Cleavable Linkers

Product

Tivdak
Elahere
Mylotarg
Zylonta
Others
Besponsa
Padcev
Adcetris
Polivy
Trodelvy
Kadcyla
Enhertu

Antigen Component

Tissue Factors
CD33
CD19
Others
CD22
Nectin 4
CD30
CD79B
Trop-2
HER2 Receptor

Antibody Component

First Generation ADCs
Fourth Generation ADCs
Second Generation ADCs
Third Generation ADCs

Singapore Antibody Drug Conjugates (ADC) Market Data Coverage Insights

Study Period	2024-2032
Base Year	2023
Unit	Revenue in USD Million
Market Value in 2024	146.17 USD Million
Market Value in 2032	488.11 USD Million
CAGR (2025-2032)	18.80%
Historic Data	2016-2023
Market Segments Covered	Indication,Conjugation Technology,Linker Technology,Cytotoxic Payloads or Warheads Component,End User,Distribution Channel,Linkers Component,Product,Antigen Component,Antibody Component

Regional Insights:

Leading Market (2024-2032): Singapore, leading in terms of revenue 146.17 USD Million in 2024
- Key Country: Singapore, leading in terms of revenue with value of 146.17 USD Million in 2024.

Segments and Scope

Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Indication
- Breast Cancer is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 65.86 USD Million in the year 2024.
- Breast Cancer is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 19.43 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Conjugation Technology
- Site-Specific Conjugation is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 85.09 USD Million in the year 2024.
- Site-Specific Conjugation is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 19.27 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Linker Technology
- Peptide Linkers is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 91.61 USD Million in the year 2024.
- Peptide Linkers is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.89 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Cytotoxic Payloads or Warheads Component
- DNA Damaging Agents is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 94.03 USD Million in the year 2024.
- DNA Damaging Agents is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.88 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By End User
- Hospitals is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 90.05 USD Million in the year 2024.
- Ambulatory Centers is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.42 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 99.00 USD Million in the year 2024.
- Retail Sales is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.83 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Linkers Component
- Cleavable Linkers is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 117.28 USD Million in the year 2024.
- Cleavable Linkers is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.84 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Product
- Enhertu is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 58.30 USD Million in the year 2024.
- Enhertu is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 19.77 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Antigen Component
- HER2 Receptor is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 89.77 USD Million in the year 2024.
- HER2 Receptor is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 19.19 % in forecast period 2025-2032.
Singapore Antibody Drug Conjugates (ADC) Market to 2032, By Antibody Component
- Third Generation ADCs is the largest segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 84.95 USD Million in the year 2024.
- Third Generation ADCs is the Fastest growing segment in Singapore Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.97 % in forecast period 2025-2032.

Singapore Antibody Drug Conjugates (ADC) Market Company Share Analysis

Company Name
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Gilead Sciences, Inc.
DAIICHI SANKYO COMPANY, LIMITED
F. Hoffmann-La Roche Ltd.

Singapore Antibody Drug Conjugates (ADC) Market Geographical Sales Distribution, 2018-2032 USD Million

Singapore Antibody Drug Conjugates (ADC) Market Company Profiling

Industry Related Reports

Asia-Pacific Discharge Inks Market for Textile Industry Market

Europe Discharge Inks Market for Textile Industry Market

North America Discharge Inks Market for Textile Industry Market

Middle East & Africa Discharge Inks Market for Textile Industry Market

South America Discharge Inks Market for Textile Industry Market

United Arab Emirates Discharge Inks Market for Textile Industry Market

Argentina Discharge Inks Market for Textile Industry Market

Australia Discharge Inks Market for Textile Industry Market

Belgium Discharge Inks Market for Textile Industry Market

Brazil Discharge Inks Market for Textile Industry Market

Frequently Asked Questions

What are the primary segments covered in the Singapore Antibody Drug Conjugates (ADC) Market?

The Singapore Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Indication,Conjugation Technology,Linker Technology,Cytotoxic Payloads or Warheads Component,End User,Distribution Channel,Linkers Component,Product,Antigen Component,Antibody Component.

What is the current market size of the Singapore Antibody Drug Conjugates (ADC) Market?

Singapore Antibody Drug Conjugates (ADC) Market was valued at USD 146.17(Revenue in USD Million) in 2023.

What is the expected growth rate of the Singapore Antibody Drug Conjugates (ADC) Market?

Singapore Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 18.80% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Singapore Antibody Drug Conjugates (ADC) Market?

The Cleavable Linkers segment is expected to dominate the Singapore Antibody Drug Conjugates (ADC) Market, holding a largest market share of 117.28 USD Million in 2024

Coming Soon....

Singapore Antibody Drug Conjugates (ADC) Market Scope

Singapore Antibody Drug Conjugates (ADC) Market Segmentation & Scope

Indication

Others
Genitourinary Cancer
Gastrointestinal Cancer
Gynecological Cancer
Lung Cancer
Blood Cancer (Leukemia, Lymphoma)
Breast Cancer

Conjugation Technology

Chemical Conjugation
Site-Specific Conjugation

Linker Technology

Disulfide Linkers
Hydrazone Linkers
Thioether Linkers
Peptide Linkers

Cytotoxic Payloads or Warheads Component

Microtubule Disrupting Agents
DNA Damaging Agents

End User

Home Healthcare
Others
Ambulatory Centers
Clinics
Specialty Center
Hospitals

Distribution Channel

Others
Retail Sales
Direct Tenders

Linkers Component

Non Cleavable Linkers
Cleavable Linkers

Product

Tivdak
Elahere
Mylotarg
Zylonta
Others
Besponsa
Padcev
Adcetris
Polivy
Trodelvy
Kadcyla
Enhertu

Antigen Component

Tissue Factors
CD33
CD19
Others
CD22
Nectin 4
CD30
CD79B
Trop-2
HER2 Receptor

Antibody Component

First Generation ADCs
Fourth Generation ADCs
Second Generation ADCs
Third Generation ADCs

Frequently Asked Questions

What are the primary segments covered in the Singapore Antibody Drug Conjugates (ADC) Market?

What is the current market size of the Singapore Antibody Drug Conjugates (ADC) Market?

Singapore Antibody Drug Conjugates (ADC) Market was valued at USD 146.17(Revenue in USD Million) in 2023.

What is the expected growth rate of the Singapore Antibody Drug Conjugates (ADC) Market?

Singapore Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 18.80% during the forecast period of 2024 to 2032.

What will be the market value of the Singapore Antibody Drug Conjugates (ADC) Market?

The estimated market value of the Singapore Antibody Drug Conjugates (ADC) Market for final year is USD 488.11 (USD Million).

Singapore Antibody Drug Conjugates (ADC) Market Company Profiling

Frequently Asked Questions

What are the primary segments covered in the Singapore Antibody Drug Conjugates (ADC) Market?

What is the current market size of the Singapore Antibody Drug Conjugates (ADC) Market?

Singapore Antibody Drug Conjugates (ADC) Market was valued at USD 146.17(Revenue in USD Million) in 2023.

What is the expected growth rate of the Singapore Antibody Drug Conjugates (ADC) Market?

Singapore Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 18.80% during the forecast period of 2024 to 2032.

What will be the market value of the Singapore Antibody Drug Conjugates (ADC) Market?

The estimated market value of the Singapore Antibody Drug Conjugates (ADC) Market for final year is USD 488.11 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.